25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Histogen Inc
Buy, Hold or Sell?

Let's analyze Histogen together

I guess you are interested in Histogen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Histogen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Histogen Inc

I send you an email if I find something interesting about Histogen Inc.

1. Quick Overview

1.1. Quick analysis of Histogen (30 sec.)










1.2. What can you expect buying and holding a share of Histogen? (30 sec.)

How much money do you get?

How much money do you get?
$0.46
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$3.13
Expected worth in 1 year
$-3.25
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-5.92
Return On Investment
-29,599.0%

For what price can you sell your share?

Current Price per Share
$0.02
Expected price per share
$0.02 - $0.16
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Histogen (5 min.)




Live pricePrice per Share (EOD)
$0.02
Intrinsic Value Per Share
$-49.59 - $24.51
Total Value Per Share
$-46.46 - $27.64

2.2. Growth of Histogen (5 min.)




Is Histogen growing?

Current yearPrevious yearGrowGrow %
How rich?$13.3m$20.1m-$6.8m-50.9%

How much money is Histogen making?

Current yearPrevious yearGrowGrow %
Making money-$10.4m-$14.4m$3.9m37.4%
Net Profit Margin-278.1%-1,567.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Histogen (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#594 / 949

Most Revenue
#371 / 949

Most Profit
#569 / 949

Most Efficient
#556 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Histogen?

Welcome investor! Histogen's management wants to use your money to grow the business. In return you get a share of Histogen.

First you should know what it really means to hold a share of Histogen. And how you can make/lose money.

Speculation

The Price per Share of Histogen is $0.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Histogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Histogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.13. Based on the TTM, the Book Value Change Per Share is $-1.59 per quarter. Based on the YOY, the Book Value Change Per Share is $3.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Histogen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.60-13,002.8%-2.60-13,002.8%-3.50-17,498.6%-2.52-12,622.2%-2.40-12,002.5%
Usd Book Value Change Per Share-1.59-7,971.0%-1.59-7,971.0%3.1115,535.8%-0.68-3,422.5%0.311,565.6%
Usd Dividend Per Share0.11571.2%0.11571.2%0.000.0%0.02114.2%0.0157.1%
Usd Total Gains Per Share-1.48-7,399.8%-1.48-7,399.8%3.1115,535.8%-0.66-3,308.3%0.321,622.8%
Usd Price Per Share0.83-0.83-0.33-0.81-3.03-
Price to Earnings Ratio-0.32--0.32--0.10--0.47--0.27-
Price-to-Total Gains Ratio-0.56--0.56-0.11--2.56--1.84-
Price to Book Ratio0.27-0.27-0.07-0.21-0.85-
Price-to-Total Gains Ratio-0.56--0.56-0.11--2.56--1.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.02
Number of shares50000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.110.02
Usd Book Value Change Per Share-1.59-0.68
Usd Total Gains Per Share-1.48-0.66
Gains per Quarter (50000 shares)-73,997.60-33,083.11
Gains per Year (50000 shares)-295,990.41-132,332.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
122848-318838-2960004570-136902-132342
245695-637676-5919909139-273804-264674
368543-956514-88798013709-410706-397006
491391-1275353-118397018278-547608-529338
5114239-1594191-147996022848-684510-661670
6137086-1913029-177595027417-821412-794002
7159934-2231867-207194031987-958314-926334
8182782-2550705-236793036556-1095216-1058666
9205630-2869543-266392041126-1232118-1190998
10228477-3188381-295991045695-1369020-1323330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.09.00.010.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%5.05.00.050.0%5.05.00.050.0%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%1.00.09.010.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%5.05.00.050.0%5.05.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Histogen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.594-1.5940%3.107-151%-0.685-57%0.313-609%
Book Value Per Share--3.1313.1310%4.725-34%1.400+124%2.988+5%
Current Ratio--10.90410.9040%9.274+18%5.507+98%7.132+53%
Debt To Asset Ratio--0.2990.2990%0.259+15%3.088-90%1.717-83%
Debt To Equity Ratio--0.3950.3950%0.333+19%0.508-22%0.763-48%
Dividend Per Share--0.1140.1140%-+100%0.023+400%0.011+900%
Enterprise Value--9957560.8009957560.8000%13047214.552-24%2889523.646+245%41921091.764-76%
Eps---2.601-2.6010%-3.500+35%-2.524-3%-2.401-8%
Ev To Ebitda Ratio---0.948-0.9480%-0.845-11%-7.825+725%-5.918+524%
Ev To Sales Ratio--2.6422.6420%14.197-81%3.054-14%infnan%
Free Cash Flow Per Share---2.317-2.3170%-3.458+49%-3.424+48%-2.246-3%
Free Cash Flow To Equity Per Share---1.539-1.5390%2.882-153%-1.691+10%0.590-361%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--24.512--------
Intrinsic Value_10Y_min---49.593--------
Intrinsic Value_1Y_max---1.725--------
Intrinsic Value_1Y_min---3.853--------
Intrinsic Value_3Y_max---1.997--------
Intrinsic Value_3Y_min---12.612--------
Intrinsic Value_5Y_max--1.574--------
Intrinsic Value_5Y_min---22.440--------
Market Cap85435.200-4050%3545560.8003545560.8000%1421214.552+149%3460723.646+2%26898322.064-87%
Net Profit Margin---2.781-2.7810%-15.675+464%-6.389+130%-6.965+150%
Operating Margin---2.824-2.8240%-16.914+499%-4.488+59%-6.004+113%
Operating Ratio--3.8613.8610%17.819-78%6.202-38%7.084-45%
Pb Ratio0.006-4050%0.2650.2650%0.070+276%0.206+29%0.847-69%
Pe Ratio-0.008+98%-0.319-0.3190%-0.095-70%-0.474+48%-0.271-15%
Price Per Share0.020-4050%0.8300.8300%0.333+149%0.810+2%3.027-73%
Price To Free Cash Flow Ratio-0.009+98%-0.358-0.3580%-0.096-73%-0.424+18%-1.456+307%
Price To Total Gains Ratio-0.014+98%-0.561-0.5610%0.107-624%-2.556+356%-1.838+228%
Quick Ratio--9.8939.8930%8.090+22%5.201+90%10.213-3%
Return On Assets---0.550-0.5500%-0.529-4%-0.966+76%-0.687+25%
Return On Equity---0.728-0.7280%-0.680-7%-1.069+47%-0.899+24%
Total Gains Per Share---1.480-1.4800%3.107-148%-0.662-55%0.325-556%
Usd Book Value--13376000.00013376000.0000%20186000.000-34%5981200.000+124%20056410.900-33%
Usd Book Value Change Per Share---1.594-1.5940%3.107-151%-0.685-57%0.313-609%
Usd Book Value Per Share--3.1313.1310%4.725-34%1.400+124%2.988+5%
Usd Dividend Per Share--0.1140.1140%-+100%0.023+400%0.011+900%
Usd Eps---2.601-2.6010%-3.500+35%-2.524-3%-2.401-8%
Usd Free Cash Flow---9899000.000-9899000.0000%-14773000.000+49%-14628200.000+48%-13126227.600+33%
Usd Free Cash Flow Per Share---2.317-2.3170%-3.458+49%-3.424+48%-2.246-3%
Usd Free Cash Flow To Equity Per Share---1.539-1.5390%2.882-153%-1.691+10%0.590-361%
Usd Market Cap85435.200-4050%3545560.8003545560.8000%1421214.552+149%3460723.646+2%26898322.064-87%
Usd Price Per Share0.020-4050%0.8300.8300%0.333+149%0.810+2%3.027-73%
Usd Profit---10481000.000-10481000.0000%-14405000.000+37%-14713600.000+40%-18278285.900+74%
Usd Revenue--3769000.0003769000.0000%919000.000+310%10327400.000-64%8781285.000-57%
Usd Total Gains Per Share---1.480-1.4800%3.107-148%-0.662-55%0.325-556%
 EOD+3 -5MRQTTM+0 -0YOY+19 -195Y+26 -1210Y+19 -18

3.3 Fundamental Score

Let's check the fundamental score of Histogen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.008
Price to Book Ratio (EOD)Between0-10.006
Net Profit Margin (MRQ)Greater than0-2.781
Operating Margin (MRQ)Greater than0-2.824
Quick Ratio (MRQ)Greater than19.893
Current Ratio (MRQ)Greater than110.904
Debt to Asset Ratio (MRQ)Less than10.299
Debt to Equity Ratio (MRQ)Less than10.395
Return on Equity (MRQ)Greater than0.15-0.728
Return on Assets (MRQ)Greater than0.05-0.550
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Histogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5010.449
Ma 20Greater thanMa 500.117
Ma 50Greater thanMa 1000.190
Ma 100Greater thanMa 2000.205
OpenGreater thanClose0.020
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Histogen Inc

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.

Fundamental data was last updated by Penke on 2024-11-14 19:51:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Histogen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Histogen to the Biotechnology industry mean.
  • A Net Profit Margin of -278.1% means that $-2.78 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Histogen Inc:

  • The MRQ is -278.1%. The company is making a huge loss. -2
  • The TTM is -278.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-278.1%TTM-278.1%0.0%
TTM-278.1%YOY-1,567.5%+1,289.4%
TTM-278.1%5Y-638.9%+360.8%
5Y-638.9%10Y-696.5%+57.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-278.1%-112.2%-165.9%
TTM-278.1%-221.4%-56.7%
YOY-1,567.5%-210.0%-1,357.5%
5Y-638.9%-342.2%-296.7%
10Y-696.5%-464.5%-232.0%
4.3.1.2. Return on Assets

Shows how efficient Histogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Histogen to the Biotechnology industry mean.
  • -55.0% Return on Assets means that Histogen generated $-0.55 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Histogen Inc:

  • The MRQ is -55.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -55.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-55.0%TTM-55.0%0.0%
TTM-55.0%YOY-52.9%-2.1%
TTM-55.0%5Y-96.6%+41.6%
5Y-96.6%10Y-68.7%-27.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.0%-11.3%-43.7%
TTM-55.0%-11.7%-43.3%
YOY-52.9%-11.3%-41.6%
5Y-96.6%-12.7%-83.9%
10Y-68.7%-14.1%-54.6%
4.3.1.3. Return on Equity

Shows how efficient Histogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Histogen to the Biotechnology industry mean.
  • -72.8% Return on Equity means Histogen generated $-0.73 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Histogen Inc:

  • The MRQ is -72.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -72.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-72.8%TTM-72.8%0.0%
TTM-72.8%YOY-68.0%-4.8%
TTM-72.8%5Y-106.9%+34.1%
5Y-106.9%10Y-89.9%-16.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.8%-14.2%-58.6%
TTM-72.8%-15.9%-56.9%
YOY-68.0%-14.3%-53.7%
5Y-106.9%-18.5%-88.4%
10Y-89.9%-19.3%-70.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Histogen Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Histogen is operating .

  • Measures how much profit Histogen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Histogen to the Biotechnology industry mean.
  • An Operating Margin of -282.4% means the company generated $-2.82  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Histogen Inc:

  • The MRQ is -282.4%. The company is operating very inefficient. -2
  • The TTM is -282.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-282.4%TTM-282.4%0.0%
TTM-282.4%YOY-1,691.4%+1,409.0%
TTM-282.4%5Y-448.8%+166.4%
5Y-448.8%10Y-600.4%+151.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-282.4%-222.9%-59.5%
TTM-282.4%-310.7%+28.3%
YOY-1,691.4%-223.5%-1,467.9%
5Y-448.8%-387.1%-61.7%
10Y-600.4%-498.5%-101.9%
4.3.2.2. Operating Ratio

Measures how efficient Histogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.86 means that the operating costs are $3.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Histogen Inc:

  • The MRQ is 3.861. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.861. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.861TTM3.8610.000
TTM3.861YOY17.819-13.958
TTM3.8615Y6.202-2.341
5Y6.20210Y7.084-0.882
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8612.465+1.396
TTM3.8613.253+0.608
YOY17.8193.298+14.521
5Y6.2024.788+1.414
10Y7.0846.494+0.590
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Histogen Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Histogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.90 means the company has $10.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Histogen Inc:

  • The MRQ is 10.904. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.904. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.904TTM10.9040.000
TTM10.904YOY9.274+1.630
TTM10.9045Y5.507+5.397
5Y5.50710Y7.132-1.625
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.9043.637+7.267
TTM10.9043.890+7.014
YOY9.2744.666+4.608
5Y5.5075.953-0.446
10Y7.1326.277+0.855
4.4.3.2. Quick Ratio

Measures if Histogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Histogen to the Biotechnology industry mean.
  • A Quick Ratio of 9.89 means the company can pay off $9.89 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Histogen Inc:

  • The MRQ is 9.893. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.893. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.893TTM9.8930.000
TTM9.893YOY8.090+1.803
TTM9.8935Y5.201+4.692
5Y5.20110Y10.213-5.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.8933.086+6.807
TTM9.8933.451+6.442
YOY8.0904.456+3.634
5Y5.2015.931-0.730
10Y10.2136.436+3.777
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Histogen Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Histogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Histogen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.30 means that Histogen assets are financed with 29.9% credit (debt) and the remaining percentage (100% - 29.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Histogen Inc:

  • The MRQ is 0.299. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.299. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.299TTM0.2990.000
TTM0.299YOY0.259+0.040
TTM0.2995Y3.088-2.790
5Y3.08810Y1.717+1.371
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2990.350-0.051
TTM0.2990.344-0.045
YOY0.2590.310-0.051
5Y3.0880.365+2.723
10Y1.7170.382+1.335
4.5.4.2. Debt to Equity Ratio

Measures if Histogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Histogen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 39.5% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Histogen Inc:

  • The MRQ is 0.395. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.395. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.395TTM0.3950.000
TTM0.395YOY0.333+0.062
TTM0.3955Y0.508-0.113
5Y0.50810Y0.763-0.254
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3950.394+0.001
TTM0.3950.432-0.037
YOY0.3330.380-0.047
5Y0.5080.451+0.057
10Y0.7630.490+0.273
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Histogen generates.

  • Above 15 is considered overpriced but always compare Histogen to the Biotechnology industry mean.
  • A PE ratio of -0.32 means the investor is paying $-0.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Histogen Inc:

  • The EOD is -0.008. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.319. Based on the earnings, the company is expensive. -2
  • The TTM is -0.319. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.008MRQ-0.319+0.311
MRQ-0.319TTM-0.3190.000
TTM-0.319YOY-0.095-0.224
TTM-0.3195Y-0.474+0.155
5Y-0.47410Y-0.271-0.202
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.008-2.253+2.245
MRQ-0.319-2.411+2.092
TTM-0.319-3.149+2.830
YOY-0.095-3.274+3.179
5Y-0.474-6.143+5.669
10Y-0.271-6.785+6.514
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Histogen Inc:

  • The EOD is -0.009. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.358. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.358. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.009MRQ-0.358+0.350
MRQ-0.358TTM-0.3580.000
TTM-0.358YOY-0.096-0.262
TTM-0.3585Y-0.424+0.065
5Y-0.42410Y-1.456+1.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.009-3.009+3.000
MRQ-0.358-3.259+2.901
TTM-0.358-3.730+3.372
YOY-0.096-4.574+4.478
5Y-0.424-8.371+7.947
10Y-1.456-9.287+7.831
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Histogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.27 means the investor is paying $0.27 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Histogen Inc:

  • The EOD is 0.006. Based on the equity, the company is cheap. +2
  • The MRQ is 0.265. Based on the equity, the company is cheap. +2
  • The TTM is 0.265. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.006MRQ0.265-0.259
MRQ0.265TTM0.2650.000
TTM0.265YOY0.070+0.195
TTM0.2655Y0.206+0.059
5Y0.20610Y0.847-0.642
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0061.979-1.973
MRQ0.2652.051-1.786
TTM0.2652.365-2.100
YOY0.0702.455-2.385
5Y0.2063.726-3.520
10Y0.8474.378-3.531
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Histogen Inc.

4.8.1. Institutions holding Histogen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Highlander Capital Management LLC0.000401700
Total 0.000401700.0%

4.9.2. Funds holding Histogen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-06-30Northern Trust Wilshire 50000.000502000
Total 0.000502000.0%

5.3. Insider Transactions

Insiders are holding 2.853% of the shares of Histogen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-03-30Richard W PascoeBUY200001.14
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets19,073
Total Liabilities5,697
Total Stockholder Equity14,405
 As reported
Total Liabilities 5,697
Total Stockholder Equity+ 14,405
Total Assets = 19,073

Assets

Total Assets19,073
Total Current Assets13,456
Long-term Assets5,617
Total Current Assets
Cash And Cash Equivalents 12,109
Net Receivables 99
Inventory 400
Other Current Assets 848
Total Current Assets  (as reported)13,456
Total Current Assets  (calculated)13,456
+/-0
Long-term Assets
Property Plant Equipment 5,094
Other Assets 523
Long-term Assets  (as reported)5,617
Long-term Assets  (calculated)5,617
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,234
Long-term Liabilities4,463
Total Stockholder Equity14,405
Total Current Liabilities
Short-term Debt 238
Accounts payable 382
Other Current Liabilities 595
Total Current Liabilities  (as reported)1,234
Total Current Liabilities  (calculated)1,215
+/- 19
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt4,393
Other Liabilities 79
Long-term Liabilities  (as reported)4,463
Long-term Liabilities  (calculated)4,472
+/- 9
Total Stockholder Equity
Common Stock5
Retained Earnings -88,273
Other Stockholders Equity 102,673
Total Stockholder Equity (as reported)14,405
Total Stockholder Equity (calculated)14,405
+/-0
Other
Capital Stock5
Cash and Short Term Investments 12,109
Common Stock Shares Outstanding 3,211
Current Deferred Revenue19
Liabilities and Stockholders Equity 19,073
Net Debt -7,487
Net Invested Capital 14,405
Net Tangible Assets 14,405
Net Working Capital 12,222
Property Plant and Equipment Gross 5,094
Short Long Term Debt Total 4,622



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
56,936
38,448
39,727
82,324
81,941
48,803
2,942
15,013
27,245
19,073
19,07327,24515,0132,94248,80381,94182,32439,72738,44856,936
   > Total Current Assets 
56,898
37,869
38,490
80,453
79,224
47,426
2,458
8,400
21,609
13,456
13,45621,6098,4002,45847,42679,22480,45338,49037,86956,898
       Cash And Cash Equivalents 
4,159
9,913
13,876
58,083
16,079
11,565
2,065
6,763
18,685
12,109
12,10918,6856,7632,06511,56516,07958,08313,8769,9134,159
       Short-term Investments 
52,194
27,159
22,632
18,932
58,774
29,127
0
0
0
0
000029,12758,77418,93222,63227,15952,194
       Net Receivables 
0
0
0
2,500
3,367
3,677
110
144
165
99
991651441103,6773,3672,500000
       Other Current Assets 
546
797
1,982
937
1,004
3,057
167
1,032
1,032
848
8481,0321,0321673,0571,0049371,982797546
   > Long-term Assets 
37
579
1,237
1,871
2,717
1,377
484
6,613
5,636
5,617
5,6175,6366,6134841,3772,7171,8711,23757937
       Property Plant Equipment 
23
237
345
261
179
154
415
4,682
4,831
5,094
5,0944,8314,68241515417926134523723
       Long-term Assets Other 
14
342
892
1,610
2,538
1,223
69
1,931
805
523
5238051,931691,2232,5381,61089234214
> Total Liabilities 
3,817
5,234
5,187
60,535
53,945
21,404
40,910
8,100
7,059
5,697
5,6977,0598,10040,91021,40453,94560,5355,1875,2343,817
   > Total Current Liabilities 
2,817
4,175
3,983
39,560
28,142
18,521
1,381
2,785
2,330
1,234
1,2342,3302,7851,38118,52128,14239,5603,9834,1752,817
       Short-term Debt 
0
0
0
0
0
0
114
125
127
238
238127125114000000
       Short Long Term Debt 
0
0
0
0
0
0
0
97
0
0
00970000000
       Accounts payable 
1,494
3,004
0
0
692
315
808
539
1,393
382
3821,393539808315692003,0041,494
       Other Current Liabilities 
1,323
1,172
3,983
8,663
13,970
8,446
440
2,073
791
595
5957912,0734408,44613,9708,6633,9831,1721,323
   > Long-term Liabilities 
1,000
1,059
1,204
20,975
25,802
2,883
39,529
5,315
4,729
4,463
4,4634,7295,31539,5292,88325,80220,9751,2041,0591,000
       Long term Debt Total 
0
0
1,000
0
13,158
0
0
0
0
0
0000013,15801,00000
       Other Liabilities 
0
0
0
0
2,311
246
138
118
112
79
791121181382462,3110000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
708
0
0
007080000000
> Total Stockholder Equity
53,119
33,214
34,540
21,789
27,996
27,399
-37,069
7,860
21,192
14,405
14,40521,1927,860-37,06927,39927,99621,78934,54033,21453,119
   Common Stock
2
2
2
3
3
3
3
1
5
5
5513333222
   Retained Earnings 
11
-96,750
-120,899
-150,632
-168,007
-186,629
-43,933
-62,702
-77,652
-88,273
-88,273-77,652-62,702-43,933-186,629-168,007-150,632-120,899-96,75011
   Accumulated Other Comprehensive Income 
11
-13
-8
-12
-154
-34
-39,070
-15,013
0
0
00-15,013-39,070-34-154-12-8-1311
   Capital Surplus 
0
0
155,441
172,425
196,077
214,042
218,198
0
0
0
000218,198214,042196,077172,425155,44100
   Treasury Stock0000000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue19
Cost of Revenue--
Gross Profit-19
 
Operating Income (+$)
Gross Profit-
Operating Expense-12,074
Operating Income-12,055-12,074
 
Operating Expense (+$)
Research Development3,278
Selling General Administrative8,796
Selling And Marketing Expenses-
Operating Expense12,07412,074
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-12,055
Net Interest Income0
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-12,383-12,055
EBIT - interestExpense = 0
-12,377
-12,377
Interest Expense0
Earnings Before Interest and Taxes (EBIT)--12,383
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-12,383
Tax Provision--
Net Income From Continuing Ops-12,383-12,383
Net Income-12,377
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Histogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Histogen. The general trend of Histogen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Histogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Histogen Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.05 < 0.1 < 0.16.

The bearish price targets are: 0.02 > 0.02 > 0.02.

Tweet this
Histogen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Histogen Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Histogen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Histogen Inc. The current macd is -0.05847056.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Histogen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Histogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Histogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Histogen Inc Daily Moving Average Convergence/Divergence (MACD) ChartHistogen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Histogen Inc. The current adx is 55.33.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Histogen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Histogen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Histogen Inc. The current sar is 0.19951313.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Histogen Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Histogen Inc. The current rsi is 10.45. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Histogen Inc Daily Relative Strength Index (RSI) ChartHistogen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Histogen Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Histogen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Histogen Inc Daily Stochastic Oscillator ChartHistogen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Histogen Inc. The current cci is -67.82810685.

Histogen Inc Daily Commodity Channel Index (CCI) ChartHistogen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Histogen Inc. The current cmo is -87.70194276.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Histogen Inc Daily Chande Momentum Oscillator (CMO) ChartHistogen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Histogen Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Histogen Inc Daily Williams %R ChartHistogen Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Histogen Inc.

Histogen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Histogen Inc. The current atr is 0.01060073.

Histogen Inc Daily Average True Range (ATR) ChartHistogen Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Histogen Inc. The current obv is 59,158,316.

Histogen Inc Daily On-Balance Volume (OBV) ChartHistogen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Histogen Inc. The current mfi is 16.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Histogen Inc Daily Money Flow Index (MFI) ChartHistogen Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Histogen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Histogen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Histogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5010.449
Ma 20Greater thanMa 500.117
Ma 50Greater thanMa 1000.190
Ma 100Greater thanMa 2000.205
OpenGreater thanClose0.020
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Histogen with someone you think should read this too:
  • Are you bullish or bearish on Histogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Histogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Histogen Inc

I send you an email if I find something interesting about Histogen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Histogen Inc.

Receive notifications about Histogen Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.